<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01553383</url>
  </required_header>
  <id_info>
    <org_study_id>CREC2012.037</org_study_id>
    <nct_id>NCT01553383</nct_id>
  </id_info>
  <brief_title>Comparison of Nasal Positive End Expiratory Pressure Valve to Dental Device as an Alternative Treatment for Obstructive Sleep Apnea</brief_title>
  <official_title>Comparison of Nasal Positive End Expiratory Pressure Valve to Dental Device as an Alternative Treatment for OSA</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese University of Hong Kong</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Determine the clinical efficacy in terms of Apnea Hypopnea Index (AHI), excessive daytime
      sleepiness (EDS), nocturnal oxygenation of a nasal Positive end-expiratory pressure (PEEP)
      valve &quot;Provent&quot; in obstructive sleep apnea. The hypothesis is the efficacy will be better
      than dental device.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Actual">March 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Apnea Hypopnea Index (AHI)</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>side effects as a measure of tolerability</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <condition>Adverse Effects</condition>
  <arm_group>
    <arm_group_label>Dental device</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>&quot;Provent&quot; nasal peep valve vs dental device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CPAP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>continuous positive airway pressure &quot;CPAP&quot; vs nasap peep valve &quot;Provent&quot;</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>nasal peep valve &quot;Provent&quot;</intervention_name>
    <description>application of nasal peep valve vs dental device and cpap</description>
    <arm_group_label>Dental device</arm_group_label>
    <arm_group_label>CPAP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Symptomatic patients confirmed of OSA by sleep study (PSG according to AASM criteria
             or validated level 3 portable monitoring devices with AHI &gt; 10/hr)

          -  Not using CPAP for any reasons or patients on dental device but would like to try
             alternative treatments for OSA.

          -  Able to sign informed consent and use the PEEP nasal valve.

          -  Age between 18-65 years old.

          -  Willing to attend follow up.

        Exclusion Criteria:

          -  Known nasal problems like deformities or significant rhinitis affecting application of
             PEEP nasal valve.

          -  Unable to sign consent or use PEEP nasal valve.

          -  Significant or unstable co-morbidities requiring other forms of treatment for OSA as
             priority.

          -  Coexisting sleep disordered breathing condition other than OSA requiring more complex
             treatment. E.g. central sleep apnea, significant Cheyne Stokes respiration or
             hypoventilation syndrome.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Medicine and Therapeutics, Prince of Wales Hospital, CUHK</name>
      <address>
        <city>Shatin</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 1, 2012</study_first_submitted>
  <study_first_submitted_qc>March 13, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 14, 2012</study_first_posted>
  <last_update_submitted>April 5, 2013</last_update_submitted>
  <last_update_submitted_qc>April 5, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 8, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese University of Hong Kong</investigator_affiliation>
    <investigator_full_name>To Kin Wang</investigator_full_name>
    <investigator_title>Associate consultant</investigator_title>
  </responsible_party>
  <keyword>OSA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

